Marshall Wace »

Cartesian Therapeutics shares owned by Marshall Wace

Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by Marshall Wace from 13F filings

Historical chart of Marshall Wace investment in Cartesian Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cartesian Therapeutics held by Marshall Wace consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cartesian Therapeutics by Marshall Wace

Quarter filed Position value Share count Share price at filing
2024-06-30 $811k 30k 27.01

More positions owned by Marshall Wace

Ishares-s&p 500 Etp (IVV)
Amazon.com Equity Option Put Option (AMZN)
Microsoft Corp Equity Option Put Option (MSFT)
Apple Common Stock (AAPL)
Spdr S&p 500 Etf Equity Option Call Option (SPY)
Nvidia Corp Equity Option Call Option (NVDA)
Alphabet Inc-a Common Stock (GOOGL)
Eli Lilly & Co Common Stock (LLY)
Alphabet Inc-c Common Stock (GOOG)
Adobe Common Stock (ADBE)
Meta Platforms-a Common Stock (META)
Johnson&johnson Common Stock (JNJ)
Humana Common Stock (HUM)
Boston Scientifc Common Stock (BSX)
Costco Wholesale Common Stock (COST)

View all positions for Marshall Wace

Top funds holding Cartesian Therapeutics

BlackRock
Jpmorgan Chase & Co
Artal Group
MPM Oncology Impact Management
Ikarian Capital
Vanguard Group
State Street Corporation
Geode Capital Management
Logos Global Management
Nuveen Asset Management
Marshall Wace
Sphera Funds Management
Delphi Financial
Charles Schwab Investment Management
Renaissance Technologies

View all funds holding Cartesian Therapeutics